Lysozyme: A paradigmatic molecule for the investigation of protein structure, function and misfolding

Clinica Chimica Acta

Volumn 357, Issue 2, 2005, Pages 168-172

  Merlini, Giampaolo ^a   Bellotti, Vittorio ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Amyloid fibril; Amyloidosis; Lysozyme

Indexed keywords

AMYLOID; LYSOZYME;

AMYLOIDOSIS; ARTICLE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN STRUCTURE;

AMYLOID; ANIMALS; HUMANS; LIGANDS; MURAMIDASE; PROTEIN CONFORMATION; PROTEIN FOLDING;

EID: 21244468176     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2005.03.022     Document Type: Article

References (16)

1. G. Merlini, and V. Bellotti Molecular mechanisms of amyloidosis N Engl J Med 349 2003 583 596
2. M.B. Pepys, P.N. Hawkins, D.R. Booth, D.M. Vigushin, G.A. Tennent, and A.K. Soutar Human lysozyme gene mutations cause hereditary systemic amyloidosis Nature 362 1993 553 557
3. C.W. Peters, U. Kruse, R. Pollwein, K.H. Grzeschik, and A.E. Sippel The human lysozyme gene. Sequence organization and chromosomal localization Eur J Biochem 182 1989 507 516
4. S. Valleix, S. Drunat, J.B. Philit, D. Adoue, J.C. Piette, and D. Droz Hereditary renal amyloidosis caused by a new variant lysozyme W64R in a French family Kidney Int 61 2002 907 912
5. M. Yazaki, S.A. Farrell, and M.D. Benson A novel lysozyme mutation Phe57Ile associated with hereditary renal amyloidosis Kidney Int 63 2003 1652 1657
6. D.R. Booth, M.B. Pepys, and P.N. Hawkins A novel variant of human lysozyme (T70N) is common in the normal population Hum Mutat 16 2000 180
7. D.R. Booth, M. Sunde, V. Bellotti, C.V. Robinson, W.L. Hutchinson, and P.E. Fraser Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis Nature 385 1997 787 793
8. D. Canet, M. Sunde, A.M. Last, A. Miranker, A. Spencer, and C.V. Robinson Mechanistic studies of the folding of human lysozyme and the origin of amyloidogenic behavior in its disease-related variants Biochemistry 38 1999 6419 6427
9. G. Esposito, J. Garcia, P. Mangione, S. Giorgetti, A. Corazza, and P. Viglino Structural and folding dynamics properties of T70N variant of human lysozyme J Biol Chem 278 2003 25910 25918
10. T. Klabunde, H.M. Petrassi, V.B. Oza, P. Raman, J.W. Kelly, and J.C. Sacchettini Rational design of potent human transthyretin amyloid disease inhibitors Nat Struct Biol 7 2000 312 321
11. C.N. Pace, and T. McGrath Substrate stabilization of lysozyme to thermal and guanidine hydrochloride denaturation J Biol Chem 255 1980 3862 3865
12. M. Dumoulin, A.M. Last, A. Desmyter, K. Decanniere, D. Canet, and G. Larsson A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozyme Nature 424 2003 783 788
13. S. Muyldermans Single domain camel antibodies: current status J Biotechnol 74 2001 277 302
14. M. Dumoulin, K. Conrath, A. Van Meirhaeghe, F. Meersman, K. Heremans, and L.G. Frenken Single-domain antibody fragments with high conformational stability Protein Sci 11 2002 500 515
15. E.F. Osserman, and D.P. Lawlor Serum and urinary lysozyme (muramidase) in monocytic and monomyelocytic leukemia J Exp Med 124 1966 921 952
16. C.M. Dobson, P.A. Evans, and S.E. Radford Understanding how proteins fold: the lysozyme story so far Trends Biochem Sci 19 1994 31 37